Ken Griffin Rani Therapeutics Holdings, Inc. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 452,542 shares of RANI stock, worth $877,931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
452,542
Previous 14,000
3132.44%
Holding current value
$877,931
Previous $7,000
3128.57%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RANI
# of Institutions
41Shares Held
3.84MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA885KShares$1.72 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$957,5520.62% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$587,3210.01% of portfolio
-
Geode Capital Management, LLC Boston, MA297KShares$576,0050.0% of portfolio
-
Kestra Private Wealth Services, LLC226KShares$438,7150.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $47.5M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...